Hematologic malignancies

Oncologist. 1999;4(4):287-92.
No abstract available

Publication types

  • Congress

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Disease-Free Survival
  • Female
  • Humans
  • Leukemia / drug therapy*
  • Lymphoma / drug therapy*
  • Lymphoma / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Survival Analysis